Company / Current Liabilities per Share
Voyager Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.48
FY2025
5-year range
$0.48 / $1.91
FY2021-FY2025
Trend
-57.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 3 consecutive years, from $1.91 in FY2022 to $0.48 in FY2025.
Based on SEC 10-K filings.
0.48 in FY2025 with a 5-year CAGR of -7.8%.
Improved from $1.67 to $0.48 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -36.7%
- 5-Year CAGR
- -7.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Voyager Therapeutics, Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 57.1% year-over-year.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.48 | -57.1% |
| FY2024 | $1.13 | -32.3% |
| FY2023 | $1.67 | -12.7% |
| FY2022 | $1.91 | +40.3% |
| FY2021 | $1.36 | +87.9% |
| FY2020 | $0.73 | -69.1% |
| FY2019 | $2.35 | +134.1% |
| FY2018 | $1.00 | +61.5% |
| FY2017 | $0.62 | +12.2% |
| FY2016 | $0.55 | -98.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026